title: Leukemia cutis in myelodysplastic syndrome and chronic myelomonocytic leukemia patients treated with adjusted dose 5-azacitidine.
authors.affiliation: Department of Hematology.
authors.forename: María Stefania
authors.initials: MS
authors.lastname: Infante
authors.affiliation: Department of Hematology.
authors.forename: Carolina
authors.initials: C
authors.lastname: Muñoz
authors.affiliation: Department of Hematology.
authors.forename: Cecilia
authors.initials: C
authors.lastname: Heras
authors.affiliation: Department of Hematology.
authors.forename: María Angeles
authors.initials: MA
authors.lastname: Foncillas
authors.affiliation: Department of Hematology.
authors.forename: Isabel
authors.initials: I
authors.lastname: González
authors.affiliation: Department of Hematology.
authors.forename: Irene
authors.initials: I
authors.lastname: Lucea
authors.affiliation: Department of Dermatology.
authors.forename: Eva
authors.initials: E
authors.lastname: Echavarria
authors.affiliation: Department of Pathology, Hospital Universitario Infanta Leonor, Madrid 28031, Spain.
authors.forename: Teresa
authors.initials: T
authors.lastname: Aramendi
authors.affiliation: Department of Hematology,, Universidad Complutense de Madrid, C/ Gran Vía del Este 80, Madrid 28031, Spain.
authors.forename: José Angel
authors.initials: JA
authors.lastname: Hernández
mesh_terms: D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use; D001374:Azacitidine / Q000009:adverse effects* / Q000627:therapeutic use; D001706:Biopsy; D005500:Follow-Up Studies; D006801:Humans; D015477:Leukemia, Myelomonocytic, Chronic / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000188:drug therapy*; D012867:Skin / Q000473:pathology*; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine